BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36422101)

  • 1. The Potential Role of Dysregulated miRNAs in Adolescent Idiopathic Scoliosis and 22q11.2 Deletion Syndrome.
    Montemurro N; Ricciardi L; Scerrati A; Ippolito G; Lofrese G; Trungu S; Stoccoro A
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36422101
    [No Abstract]   [Full Text] [Related]  

  • 2. Scoliosis in association with the 22q11.2 deletion syndrome: an observational study.
    Homans JF; Baldew VGM; Brink RC; Kruyt MC; Schlösser TPC; Houben ML; Deeney VFX; Crowley TB; Castelein RM; McDonald-McGinn DM
    Arch Dis Child; 2019 Jan; 104(1):19-24. PubMed ID: 29627765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 22q11.2 deletion syndrome in the relationship between congenital heart disease and scoliosis.
    Homans JF; de Reuver S; Heung T; Silversides CK; Oechslin EN; Houben ML; McDonald-McGinn DM; Kruyt MC; Castelein RM; Bassett AS
    Spine J; 2020 Jun; 20(6):956-963. PubMed ID: 31958577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion Extents Are Not the Cause of Clinical Variability in 22q11.2 Deletion Syndrome: Does the Interaction between DGCR8 and miRNA-CNVs Play a Major Role?
    Bertini V; Azzarà A; Legitimo A; Milone R; Battini R; Consolini R; Valetto A
    Front Genet; 2017; 8():47. PubMed ID: 28507561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 22q11.2 deletion syndrome as a model for idiopathic scoliosis - A hypothesis.
    Homans JF; de Reuver S; Breetvelt EJ; Vorstman JAS; Deeney VFX; Flynn JM; McDonald-McGinn DM; Kruyt MC; Castelein RM
    Med Hypotheses; 2019 Jun; 127():57-62. PubMed ID: 31088649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as the cause of schizophrenia in 22q11.2 deletion carriers, and possible implications for idiopathic disease: a mini-review.
    Forstner AJ; Degenhardt F; Schratt G; Nöthen MM
    Front Mol Neurosci; 2013 Dec; 6():47. PubMed ID: 24367288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 22q11.2 Deletion Syndrome as a Human Model for Idiopathic Scoliosis.
    de Reuver S; Homans JF; Schlösser TPC; Houben ML; Deeney VFX; Crowley TB; Stücker R; Pasha S; Kruyt MC; McDonald-McGinn DM; Castelein RM
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review.
    Homans JF; Tromp IN; Colo D; Schlösser TPC; Kruyt MC; Deeney VFX; Crowley TB; McDonald-McGinn DM; Castelein RM
    Am J Med Genet A; 2018 Oct; 176(10):2104-2120. PubMed ID: 29159873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome.
    Brzustowicz LM; Bassett AS
    Front Genet; 2012; 3():291. PubMed ID: 23248646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia Risk Mediated by microRNA Target Genes Overlapped by Genome-Wide Rare Copy Number Variation in 22q11.2 Deletion Syndrome.
    Ying S; Heung T; Zhang Z; Yuen RKC; Bassett AS
    Front Genet; 2022; 13():812183. PubMed ID: 35495153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Variability of 22q11.2 Deletion Syndrome: The Role of Epigenetic Factors.
    Cillo F; Coppola E; Habetswallner F; Cecere F; Pignata L; Toriello E; De Rosa A; Grilli L; Ammendola A; Salerno P; Romano R; Cirillo E; Merla G; Riccio A; Pignata C; Giardino G
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.
    Scott JA; Goodrich-Hunsaker N; Kalish K; Lee A; Hunsaker MR; Schumann CM; Carmichael OT; Simon TJ
    J Psychiatry Neurosci; 2016 Apr; 41(3):203-13. PubMed ID: 26599134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust and replicable functional brain signatures of 22q11.2 deletion syndrome and associated psychosis: a deep neural network-based multi-cohort study.
    Supekar K; de Los Angeles C; Ryali S; Kushan L; Schleifer C; Repetto G; Crossley NA; Simon T; Bearden CE; Menon V
    Mol Psychiatry; 2024 Apr; ():. PubMed ID: 38605171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome.
    Niarchou M; Martin J; Thapar A; Owen MJ; van den Bree MB
    Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):730-8. PubMed ID: 26400629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
    Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
    Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Face processing in 22q11.2 deletion syndrome: atypical development and visual scanning alterations.
    Zaharia A; Schneider M; Glaser B; Franchini M; Menghetti S; Schaer M; Debbané M; Eliez S
    J Neurodev Disord; 2018 Aug; 10(1):26. PubMed ID: 30157749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.